Friday headlines: Fuggetaboutit
A study finds severe Covid-19 patients who take the antiviral medicine remdesivir experience rapid recoveries, with nearly all patients discharged in less than a week from a Chicago hospital. In case you missed it: TMN’s Rosecrans Baldwin profiles the scientist who figured out remdesivir’s capabilities. New guidelines